{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:15Z","timestamp":1790916915668,"version":"4.1.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perivascular fat attenuation index (FAI) derived from coronary computed tomography angiography (CCTA) is a novel imaging biomarker of coronary inflammation. However, its incremental value in predicting functional myocardial ischemia, defined by CT-derived fractional flow reserve (CT-FFR), beyond traditional cardiovascular risk factors and epicardial adipose tissue (EAT) volume remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 380 consecutive patients who underwent clinically indicated CCTA with CT-FFR evaluation were retrospectively analyzed. Functional ischemia was defined as CT-FFR \u22640.80. Patients were stratified into low and high FAI groups based on the optimal cutoff value of \u221281.32 Hounsfield Units (HU). Multivariate logistic regression analysis was performed to identify independent predictors of ischemia. The incremental diagnostic performance of adding FAI to a baseline clinical model was assessed using area under the receiver operating characteristic curve (AUC), continuous net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Despite comparable baseline profiles for low-density lipoprotein cholesterol, body mass index, and glycemic status (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;gt;\u20090.05), patients in the high FAI group exhibited significantly lower CT-FFR values (0.75\u2009\u00b1\u20090.13 vs. 0.79\u2009\u00b1\u20090.12,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0017). After adjusting for age, gender, traditional cardiovascular risk factors, and EAT volume, average FAI remained a robust independent predictor of functional ischemia [Adjusted Odds Ratio [OR]: 1.056 per 1 HU increase; 95% Confidence Interval [CI]: 1.019\u20131.096;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004]. Notably, EAT volume did not reach statistical significance in the multivariate model (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.584). The addition of FAI to the clinical model resulted in a modest, non-significant improvement in AUC (0.731 vs. 0.707,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.087), but yielded significant improvement in risk reclassification (continuous NRI: 0.339,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001; IDI: 0.024,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). Subgroup analysis demonstrated a consistent risk trend across varying degrees of stenosis, age, and body mass index categories (OR range: 1.03\u20131.07). DCA confirmed superior net clinical benefit for the FAI-integrated model across a wide threshold probability range (25%\u201375%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Coronary perivascular FAI is an independent imaging marker for CT-FFR-defined functional ischemia and provides incremental value beyond traditional risk factors and EAT volume. These findings support FAI as a non-invasive marker of coronary inflammation that may refine risk stratification for functionally significant coronary artery disease. However, as CT-FFR mainly reflects epicardial physiology, the association between FAI and microvascular dysfunction remains to be determined.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1950032","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:36:29Z","timestamp":1790915789000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Perivascular fat attenuation index improves the identification of functional myocardial ischemia beyond traditional risk factors: a coronary CT angiography-derived fractional flow reserve study"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhihong","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Health Management Center, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmei","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/jebm.12573","article-title":"Diagnostic performance of angiography-derived fractional flow reserve and CT-derived fractional flow reserve: a systematic review and Bayesian network meta-analysis","volume":"17","author":"Chen","year":"2024","journal-title":"J Evid Based Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e002852","DOI":"10.1136\/openhrt-2024-002852","article-title":"Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis","volume":"11","author":"Odanovi\u0107","year":"2024","journal-title":"Open Heart"},{"key":"B6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcmg.2019.03.003","article-title":"1-Year impact on medical practice and clinical outcomes of FFRCT: the ADVANCE registry","volume":"13","author":"Patel","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2021.12.013","article-title":"Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease","volume":"348","author":"Mehta","year":"2022","journal-title":"Int J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","article-title":"Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers","volume":"44","author":"Antoniades","year":"2023","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12933-024-02549-9","article-title":"Perivascular adipose tissue: a central player in the triad of diabetes, obesity, and cardiovascular health","volume":"23","author":"Queiroz","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11883-019-0817-3","article-title":"Perivascular adipose tissue and coronary atherosclerosis: from biology to imaging phenotyping","volume":"21","author":"Lin","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/S0140-6736(24)00596-8","article-title":"Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study","volume":"403","author":"Chan","year":"2024","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MCA.0000000000001583","article-title":"Coronary perivascular adipose tissue fat attenuation index in patients with ischemia with no obstructive coronary arteries and coronary microvascular dysfunction","volume":"37","author":"Smilowitz","year":"2026","journal-title":"Coron Artery Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"eaal2658","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.scib.2024.03.053","article-title":"Diagnostic and prognostic performance of artificial intelligence-based fully-automated on-site CT-FFR in patients with CAD","volume":"69","author":"Guo","year":"2024","journal-title":"Sci Bull (Beijing)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10760296241313459","DOI":"10.1177\/10760296241313459","article-title":"Correlation between fat attenuation index and plaque parameters in coronary CT angiography: an observational study in stable coronary artery disease","volume":"31","author":"Guo","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"B16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jcct.2020.02.002","article-title":"Peri-coronary inflammation is associated with findings on coronary computed tomography angiography and fractional flow reserve","volume":"14","author":"Hoshino","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/medicina62040630","article-title":"Coronary plaque vulnerability and pericoronary adipose tissue inflammation: emerging insights from advanced CT imaging","volume":"62","author":"M\u00e1ty\u00e1s","year":"2026","journal-title":"Medicina (Kaunas)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1303529","DOI":"10.3389\/fcvm.2024.1303529","article-title":"Relationship between peri-coronary inflammation and coronary vascular function in patients with suspected coronary artery disease","volume":"11","author":"Chen","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/RTI.0000000000000632","article-title":"Computed tomography-derived characterization of pericoronary, epicardial, and paracardial adipose tissue and its association with myocardial ischemia as assessed by computed fractional flow reserve","volume":"38","author":"Duncker","year":"2023","journal-title":"J Thorac Imaging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1950032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:36:44Z","timestamp":1790915804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1950032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2026.1950032"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1950032","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1950032"}}